Open AccessCXCL12 rs18011157 polymorphısm in patients wıth non-Hodgkin's lymphoma: Is it associated with poor outcome?
Author(s) -
Gülsüm Emel Pamuk,
Hilmi Tozkır,
Mehmet Şevki Uyanık,
Hakan Gürkan,
Julide Duymaz,
Ömer Nurı Pamuk
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.203596
Subject(s) - medicine , gastroenterology , genotype , lymphoma , international prognostic index , non hodgkin's lymphoma , univariate analysis , multivariate analysis , lactate dehydrogenase , b symptoms , rituximab , biology , genetics , gene , enzyme , biochemistry
We studied CXCL12-related rs18011157 polymorphism in non-Hodgkin lymphoma (NHL) patients. We also determined the effect of this polymorphism on clinical features and outcome of NHL.